KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

Lignende værker

• Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
  af: Cremolini, C, et al.
  Udgivet: (2010)
• Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
  af: Fiore, F Di, et al.
  Udgivet: (2008)
• Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
  af: Gattenlöhner, S., et al.
  Udgivet: (2009)
• KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
  af: Rouleau, E, et al.
  Udgivet: (2008)
• KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
  af: Soulières, D., et al.
  Udgivet: (2010)